These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21451853)

  • 21. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
    Yang YJ; Tao X; Hou Q; Chen JF
    Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organically modified titania nanoparticles for sustained drug release applications.
    Sethi K; Roy I
    J Colloid Interface Sci; 2015 Oct; 456():59-65. PubMed ID: 26093234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New amphiphilic carriers forming pH-sensitive nanoparticles for nucleic acid delivery.
    Xu R; Wang XL; Lu ZR
    Langmuir; 2010 Sep; 26(17):13874-82. PubMed ID: 20672851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
    Lu J; Liong M; Zink JI; Tamanoi F
    Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications.
    Xuan S; Wang F; Lai JM; Sham KW; Wang YX; Lee SF; Yu JC; Cheng CH; Leung KC
    ACS Appl Mater Interfaces; 2011 Feb; 3(2):237-44. PubMed ID: 21229966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells.
    Liu HM; Wu SH; Lu CW; Yao M; Hsiao JK; Hung Y; Lin YS; Mou CY; Yang CS; Huang DM; Chen YC
    Small; 2008 May; 4(5):619-26. PubMed ID: 18491363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
    Rosenholm JM; Sahlgren C; Lindén M
    Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.
    Wang C; Cheng L; Liu Z
    Biomaterials; 2011 Feb; 32(4):1110-20. PubMed ID: 20965564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous materials for drug delivery.
    Vallet-Regí M; Balas F; Arcos D
    Angew Chem Int Ed Engl; 2007; 46(40):7548-58. PubMed ID: 17854012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
    Hu QD; Fan H; Ping Y; Liang WQ; Tang GP; Li J
    Chem Commun (Camb); 2011 May; 47(19):5572-4. PubMed ID: 21468443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
    Hong S; Leroueil PR; Majoros IJ; Orr BG; Baker JR; Banaszak Holl MM
    Chem Biol; 2007 Jan; 14(1):107-15. PubMed ID: 17254956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
    Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
    J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial exopolysaccharide based nanoparticles for sustained drug delivery, cancer chemotherapy and bioimaging.
    Raveendran S; Poulose AC; Yoshida Y; Maekawa T; Kumar DS
    Carbohydr Polym; 2013 Jan; 91(1):22-32. PubMed ID: 23044101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
    Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
    Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hollow spherical mesoporous phosphosilicate nanoparticles as a delivery vehicle for an antibiotic drug.
    Das SK; Bhunia MK; Chakraborty D; Khuda-Bukhsh AR; Bhaumik A
    Chem Commun (Camb); 2012 Mar; 48(23):2891-3. PubMed ID: 22310528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperbranched polysiloxysilane nanoparticles: surface charge control of nonviral gene delivery vectors and nanoprobes.
    Kim WJ; Bonoiu AC; Hayakawa T; Xia C; Kakimoto MA; Pudavar HE; Lee KS; Prasad PN
    Int J Pharm; 2009 Jul; 376(1-2):141-52. PubMed ID: 19409467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles.
    Zhao YL; Li Z; Kabehie S; Botros YY; Stoddart JF; Zink JI
    J Am Chem Soc; 2010 Sep; 132(37):13016-25. PubMed ID: 20799689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles.
    Thomas CR; Ferris DP; Lee JH; Choi E; Cho MH; Kim ES; Stoddart JF; Shin JS; Cheon J; Zink JI
    J Am Chem Soc; 2010 Aug; 132(31):10623-5. PubMed ID: 20681678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.